Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Dementia01:30

Dementia

656
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
656
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

542
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
542
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

575
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
575
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

687
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
687

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 3D skeletal muscle system for disease modelling and secretome profiling of Duchenne muscular dystrophy.

Skeletal muscle·2026
Same author

Climate Change, Epigenetics, Microbiota, and Health.

International journal of environmental research and public health·2026
Same author

CD169<sup>+</sup> and HLA-DR<sup>+</sup> extracellular vesicles are highly represented in human plasma and dynamically expressed in SARS-CoV-2 infection and long COVID-associated sequelae.

Frontiers in cellular and infection microbiology·2026
Same author

Glowing Spicules and Structural Collapse: A Single-Cell Insight into the Oxidative Aging of Favism Erythrocytes.

International journal of molecular sciences·2026
Same author

Pentosan Polysulfate and Heparin Exhibit Comparable Interactions with Platelet Factor 4, Suggesting a Potential Risk of Thrombocytopenia.

ACS omega·2026
Same author

The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review.

Nutrients·2025

Related Experiment Video

Updated: Mar 12, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K

Vascular dysfunction-associated with Alzheimer's disease.

Cristiana Carelli-Alinovi1, Simone Dinarelli2, Marco Girasole2

  • 1Institute of Biochemistry and Clinical Biochemistry, Catholic University, School of Medicine, Rome, Italy.

Clinical Hemorheology and Microcirculation
|November 5, 2016
PubMed
Summary

Red blood cells (RBCs) may contribute to Alzheimer's disease (AD) by interacting with amyloid beta (Aβ). This interaction, mediated by acetylcholinesterase (AChE) on RBCs, could impair oxygen delivery and worsen AD pathology.

Keywords:
Alzheimer diseaseAmyloid beta peptideNO metabolitesacetylcholinesterasenitric oxide synthasered blood cell

More Related Videos

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

41.0K
A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

1.6K

Related Experiment Videos

Last Updated: Mar 12, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

41.0K
A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

1.6K

Area of Science:

  • Biochemistry
  • Neuroscience
  • Hematology

Background:

  • Red blood cells (RBCs) are crucial for microcirculation due to their deformability.
  • Abnormalities in RBCs may contribute to Alzheimer's disease (AD) by causing hypoxia due to impaired oxygen delivery.
  • RBC membranes possess high levels of acetylcholinesterase (AChE), an enzyme also implicated in neuronal amyloid beta (Aβ) toxicity.

Purpose of the Study:

  • To investigate a novel model of RBC interaction with amyloid beta peptide 1-42 (Aβ).
  • To explore the potential role of RBC-associated AChE in mediating Aβ toxicity in the bloodstream.
  • To examine the influence of Nitric Oxide (NO) metabolism on RBC mechanical properties and its link to AChE in the context of AD.

Main Methods:

  • Developing a new model system utilizing RBCs and Aβ.
  • Analyzing the interaction between Aβ and RBC membrane-bound AChE.
  • Investigating the role of NO metabolism in RBC membrane regulation and its connection to AChE activity.

Main Results:

  • Aβ interaction with RBCs is proposed to occur via AChE on the RBC surface.
  • This interaction may mimic neuronal mechanisms, potentially increasing Aβ toxicity in circulation.
  • RBC mechanical properties, regulated by pathways involving NO metabolism, are linked to AChE, suggesting a complex interplay in AD pathogenesis.

Conclusions:

  • RBCs and their associated AChE represent a potential factor in Alzheimer's disease progression.
  • The interaction between Aβ and RBCs may contribute to hypoxia and neurodegeneration.
  • Further research into NO metabolism and AChE on RBCs could reveal new therapeutic targets for AD.